Sensorion SA (EPA:ALSEN)
6.61
-0.53 (-7.38%)
Oct 2, 2026, 5:35 PM CET
Sensorion Market Cap
Sensorion has a market cap or net worth of €68.12 million as of October 2, 2026. Its market cap has decreased by -34.67% in one year.
Market Cap
68.12M
Enterprise Value
-17.18M
Revenue
6.16M
Ranking
n/a
PE Ratio
n/a
Stock Price
€6.61
ChartMarket Cap Chart
Since April 21, 2015, Sensorion's market cap has increased from 20.46M to 68.12M, an increase of 232.98%. That is a compound annual growth rate of 11.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 68.12M | -32.73% |
| Dec 31, 2025 | 101.25M | -47.00% |
| Dec 31, 2024 | 191.03M | 137.65% |
| Dec 29, 2023 | 80.38M | 171.97% |
| Dec 30, 2022 | 29.56M | -80.74% |
| Dec 31, 2021 | 153.45M | 33.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Valerio Therapeutics Société anonyme | 275.20M |
| Transgene | 199.66M |
| Innate Pharma | 128.18M |
| Cellectis | 92.40M |
| ABIONYX Pharma | 74.43M |
| OSE Immunotherapeutics | 52.97M |
| Adocia | 52.36M |
| THX Pharma Société Anonyme | 48.63M |